SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-053010
Filing Date
2020-11-10
Accepted
2020-11-10 16:34:08
Documents
57
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q stsa-10q_20200930.htm 10-Q 2478067
2 EX-31.1 stsa-ex311_9.htm EX-31.1 18871
3 EX-31.2 stsa-ex312_6.htm EX-31.2 18701
4 EX-32.1 stsa-ex321_10.htm EX-32.1 9914
5 EX-32.2 stsa-ex322_7.htm EX-32.2 9836
  Complete submission text file 0001564590-20-053010.txt   6793619

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT stsa-20200930.xml EX-101.INS 1299807
7 XBRL TAXONOMY EXTENSION SCHEMA stsa-20200930.xsd EX-101.SCH 43241
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE stsa-20200930_cal.xml EX-101.CAL 41082
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE stsa-20200930_def.xml EX-101.DEF 134845
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE stsa-20200930_lab.xml EX-101.LAB 344682
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE stsa-20200930_pre.xml EX-101.PRE 253872
Mailing Address 400 OYSTER POINT BOULEVARD SUITE 221 SOUTH SAN FRANCISCO CA 64080
Business Address 400 OYSTER POINT BOULEVARD SUITE 221 SOUTH SAN FRANCISCO CA 64080 415-505-0809
Satsuma Pharmaceuticals, Inc. (Filer) CIK: 0001692830 (see all company filings)

IRS No.: 813039831 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39041 | Film No.: 201301645
SIC: 2834 Pharmaceutical Preparations